MiniMed Group Inc. (MMED)
NASDAQ: MMEDHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MMED stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.50B
- Forward P/E
- 22.52
- EPS (TTM)
- -$1.53
- Dividend yield
- None
- 52-week range
- 10.65 – 24.43
- Day range
- 15.92 – 16.79
- Volume / Avg
- 4.57M / 8.48M
- Beta
- —
- Shares outstanding
- 281.35M
- Next earnings
- Nov 24, 2026
52-week range
MMED stock today
Shares of MiniMed Group (MMED) finished lower on Nov 20 at $16.01, a drop of 1.54% or $0.25 per share, versus the S&P 500's 3.70% decline. Shares are 34.5% below their 52-week high of $24.43, set on Sep 2, 2026 and 50.3% above the 52-week low of $10.65, in the middle of the past year's range. MiniMed Group has posted a net loss over the last twelve months (EPS of -$1.53), so its P/E ratio is not meaningful.
The company is scheduled to report Oct/2026 results on Nov 24 before the market opens; analysts expect EPS of $0.10.
Summary generated from market data by MetaCap's automated system. Methodology
About MiniMed Group
Company profileMiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Ms. Que Thanh Dallara
- Headquarters
- Northridge, CA
- Employees
- 8,000
- IPO year
- 2026
- Website
- minimed.com
Financial highlights
Full financialsIn fiscal 2026, MiniMed Group generated $3.10 billion in revenue, up 14.3% from fiscal 2025, its 2nd consecutive year of revenue growth. MiniMed Group reported a net loss of $333.0 million, compared with a loss of $213.0 million a year earlier. Gross margin was 54.2% (down from 56.3%) and operating margin -6.1%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B |
| Growth | +14.25% | +9.96% | — |
| Net income | $-333.00M | $-213.00M | $-112.00M |
| EPS (diluted) | $-1.30 | $-0.84 | $-0.44 |
Analyst forecast
ForecastConsensus (16 analysts)
buy
Avg. price target
$25.33+58.21%
- Strong buy 0
- Buy 12
- Hold 3
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 24, 2026
- EPS estimate
- $0.10
- Last reported (Q1 2027)
- Sep 8, 2026
- EPS actual vs est.
- $0.00 vs —
MMED news
All MMED news- Medtronic Is About to Report Its First Earnings Since Spinning Off MiniMed. Should You Buy the Stock Before Nov. 24?NasdaqMDT, MMED
- MiniMed Launches MiniMed Flex Pump in Europe to Expand Diabetes Care (Revised)NasdaqMMED, MMSI, OPK, GMED
- MiniMed Launches MiniMed Flex Pump in Europe to Expand Diabetes CareNasdaqMMED, MMSI, OPK, GMED
- MiniMed introduceert MiniMed Flex™, de kleinste en meest discrete insulinepomp, in Europa.PR Newswire
- MiniMed Launches MiniMed Flex™, its Smallest and Most Discrete Insulin Pump, in EuropePR Newswire
- MiniMed Gains FDA Approval For Tubeless Insulin PumpNasdaqMMED, MKC.V
- FDA Clears MiniMed Fit™ -- World's First and Only Tubeless Insulin Pump with Up to Seven-Day Wear and Zero InterruptionsPR Newswire
- BTIG sees upside across medtech stocks as iRhythm, Delcath and MiniMed stand outInvesting.comMMED, IRTC
MiniMed Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ICUIICU Medical Inc. | 172.52 | -1.84% | $4.31B | vs MMED |
| STVNStevanato Group S.p.A. | 15.65 | -1.76% | $4.27B | vs MMED |
| HTFLHeartflow Inc. | 46.69 | +4.62% | $4.10B | vs MMED |
| MMSIMerit Medical Systems Inc. | 84.34 | -0.08% | $5.05B | vs MMED |
| HAEHaemonetics Corporation | 120.16 | -0.17% | $5.47B | vs MMED |
| NVSTEnvista Holdings Corporation | 22.91 | -1.55% | $3.67B | vs MMED |
| PLSEPulse Biosciences Inc | 45.55 | +2.57% | $3.35B | vs MMED |
| IRTCiRhythm Holdings Inc. | 94.72 | +0.51% | $3.18B | vs MMED |
Indexes, lists and sector
MiniMed Group stock FAQ
What is MiniMed Group's stock price today?
MMED last traded at $16.01 as of Nov 20, 4:00 PM EST, down 1.54% on the day. Prices are delayed at least 15 minutes.
When is MiniMed Group's next earnings date?
MiniMed Group is expected to report earnings on Tuesday, November 24, 2026. Analysts expect EPS of $0.10.
Who is MiniMed Group's CEO?
Ms. Que Thanh Dallara is the chief executive officer of MiniMed Group Inc., which has about 8,000 employees.
What is the MMED 52-week high?
The 52-week high for MMED is $24.43 and the 52-week low is $10.65. The stock is currently 34.5% below its high.